Swander Pace Capital forms Clarion Brands, acquires six OTC brands from DSE Healthcare

The portfolio includes leading brands built by strong levels of professional recommendations which have demonstrated excellent growth potential. The brands Lipo-Flavonoid®, Certain Dri®, Cystex®, Albolene, Absorbine Jr.®, and Anti-Monkey Butt, are sold in food, drug, and mass retailers throughout the U.S. and Canada. Clarion Brands represents Swander Pace’s third platform investment in the OTC industry. No financial terms were released.

• Lipo-Flavonoid is the #1 ear-nose-throat doctor-recommended treatment for tinnitus, or ringing in the ears.
• Certain Dri is the #1 doctor-recommended treatment for controlling excessive underarm sweating, or hyperhidrosis.
• Cystex is the #2 urinary pain reliever that helps women manage the pain and discomfort of urinary tract infections.
• Albolene is a moisturizing makeup remover that cleanses mascara and lipstick.
• Absorbine Jr. is a topical pain reliever made from menthol and natural herbal extracts.
• Anti-Monkey Butt is a powder that absorbs excess sweat and minimizes frictional skin discomfort associated with chaffing and rashes.

"We are excited to add these OTC brands to the newly formed Clarion Brands Holding Co. and believe there is significant opportunity to capitalize on the brands’ momentum and drive continued growth," said Mo Stout, Managing Director at Swander Pace.

"We have deep experience in the OTC and personal care industry and feel we are in an ideal position to assist the management team in investing in brand development, driving cost improvements, and expanding distribution. With a combination of best-in-class brands and our experience in growing consumer products companies, we look forward to building Clarion into a leader in the OTC category."

Kirkland & Ellis LLP served as legal adviser to Swander Pace on the acquisition.